Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series — Emma L. Mitchell (2018) | RDL Network
Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series
Marcel Batten, Erin R. Shanahan, Inês Pires da Silva, Chandra Mani Adhikari, Jordan W. Conway, Annie Tasker, Alexander M. Menzies, James S. Wilmott, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Christian U. Blank, Andrew Holmes, Richard A Scolyer, Georgina V. Long
Marcel Batten, Erin R. Shanahan, Inês Pires da Silva, Chandra Mani Adhikari, Jordan W. Conway, Annie Tasker, Alexander M. Menzies, James S. Wilmott, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Christian U. Blank, Andrew Holmes, Richard A Scolyer, Georgina V. Long
Justin M. Balko, Lydia Yao, Siwei Zhang, Catherine C. Fahey, Alexandra M. Haugh, Andrea L. Davis, Eric Mukherjee, Christian Hammer, Elizabeth J. Phillips, Adrian Bejan, Yaomin Xu, Douglas B. Johnson
Discussion(0)
No comments yet. Be the first to comment.